HerDox

N/A

Report date: 2025/01/26 18:35:31

Base Information

Drug NameHerDox
Drug Alias Namedoxorubicin + HerPBK10 (University of California Los Angeles/Cedars-Sinai Medical Center)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionReceptor tyrosine-protein kinase erbB-3 antagonists
TargetsReceptor tyrosine-protein kinase erbB-3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California, Los Angeles
China Registration ClassN/A

Develop Information

Active CompaniesCedars-Sinai Medical CenterUniversity Of California, Los Angeles
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A